Generex Biotechnology Corporation
GNBTQ
OTC PK
| 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | 04/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -37.26M | -52.11M | -34.94M | -33.34M | -26.45M |
| Total Depreciation and Amortization | 1.16M | 1.11M | 1.06M | 1.00M | 557.20K |
| Total Amortization of Deferred Charges | 1.60M | 1.80M | 2.52M | 4.42M | 5.79M |
| Total Other Non-Cash Items | 2.50M | 19.88M | 5.94M | 11.71M | 5.08M |
| Change in Net Operating Assets | 29.62M | 25.50M | 19.80M | 10.08M | 8.01M |
| Cash from Operations | -2.37M | -3.82M | -5.62M | -6.13M | -7.01M |
| Capital Expenditure | 0.00 | 0.00 | -200.00 | -4.70K | -8.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 40.70K |
| Cash Acquisitions | 0.00 | 0.00 | 0.00 | 49.30K | 49.30K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | 0.00 | 0.00 | -200.00 | 44.70K | 81.10K |
| Total Debt Issued | 2.30M | 1.26M | 3.66M | 6.64M | 7.02M |
| Total Debt Repaid | -2.37M | -127.50K | -60.00K | -935.70K | -956.80K |
| Issuance of Common Stock | 3.89M | 3.19M | 2.33M | 109.80K | 109.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -172.40K | -170.40K | -- | -- | -228.80K |
| Cash from Financing | 3.64M | 4.16M | 5.93M | 5.81M | 5.95M |
| Foreign Exchange rate Adjustments | -11.90K | -11.90K | -13.80K | -11.90K | -10.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.26M | 327.00K | 293.30K | -283.00K | -991.20K |
